RARE logo

RARE Net Income

Annual Net Income

-$606.64 M
+$100.78 M+14.25%

December 31, 2023

Summary

Performance

1-Year Change

+14.25%

3-Year Change

-225.16%

5-Year Change

-206.99%

15-Year Change

-100.78%

RARE Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

1.85%
RARE annual net profit is higher than 1.85% of companies in Healthcare sector

High & Low

All-time High

-$6.85 M

3-Year Low

-$707.42 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RARE previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 14, 2025
RARE next annual earnings announcement is scheduled for Feb 14, 2025

OtherRAREprofitabilitymetrics:

Annual Net Margin

-139.70%
RARE annual net profit margin is -139.70%

Annual Revenue

$434.25 M
RARE annual revenue is $434.25 million

Annual Gross Profit

$389.04 M
RARE annual gross profit is $389.04 million

Annual EPS

-$8.25
RARE annual earnings per share is -$8.25

Quarterly Net Income

-$133.52 M
-$1.92 M-1.46%

September 30, 2024

Summary

Performance

3-Month Change

-1.46%

1-Year Change

+16.37%

3-Year Change

-82.9%

5-Year Change

-18.16%

RARE Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

1.86%
RARE quarterly net profit is higher than 1.86% of companies in Healthcare sector

High & Low

All-time High

$30.25 M
RARE quarterly net profit is currently -541.33% below its historical high of $30.25 million

3-Year Low

-$245.11 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RARE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
RARE next earnings announcement is scheduled for Feb 14, 2025

OtherRAREprofitabilitymetrics:

Quarterly Net Margin

-95.71%
RARE quarterly net profit margin is -95.71%

Quarterly Revenue

$139.49 M
RARE quarterly revenue is $139.49 million

Quarterly Gross Profit

$118.47 M
RARE quarterly gross profit is $118.47 million

Quarterly EPS

-$1.40
RARE quarterly earnings per share is -$1.40

TTM Net Income

-$558.99 M
+$26.13 M+4.47%

September 30, 2024

Summary

Performance

3-Month Change

+4.47%

1-Year Change

+12.01%

3-Year Change

-57.21%

5-Year Change

-38.8%

RARE TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

1.95%
RARE TTM net profit is higher than 1.95% of companies in Healthcare sector

High & Low

All-time High

-$4.93 M

3-Year Low

-$720.74 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RARE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
RARE next earnings announcement is scheduled for Feb 14, 2025

OtherRAREprofitabilitymetrics:

Annual Net Margin

-139.70%
RARE annual net profit margin is -139.70%

TTM Revenue

$522.75 M
RARE TTM revenue is $522.75 million

TTM Gross Profit

$450.86 M
RARE TTM gross profit is $450.86 million

TTM EPS

-$6.47
RARE TTM earnings per share is -$6.47

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$606.64 M
RARE annual net profit is -$606.64 million

Annual Revenue

$434.25 M
RARE annual revenue is $434.25 million

Annual Cost Of Goods Sold

$45.21 M
RARE annual cost of goods sold is $45.21 million

Annual Operating Expenses

$958.25 M
RARE annual total operating expenses is $958.25 million

Annual Interest Expense

$66.00 M
RARE annual interest expense is $66.00 million

Annual Income Tax

-$1.82 M
RARE annual income tax is -$1.82 million

RARE Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.3%+16.4%+12.0%
3 y3 years-225.2%-82.9%-57.2%
5 y5 years-207.0%-18.2%-38.8%

RARE Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-33.6%+14.3%-9.0%+45.5%-23.1%+22.4%
5 y5-year-225.2%+14.3%-627.4%+45.5%-199.6%+22.4%
alltimeall time-8757.3%+14.3%-541.3%+45.5%<-9999.0%+22.4%

Ultragenyx Pharmaceutical Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$133.52 M(+1.5%)
-$558.99 M(-4.5%)
Jun 2024
-
-$131.60 M(-22.9%)
-$585.12 M(-4.6%)
Mar 2024
-
-$170.68 M(+38.6%)
-$613.35 M(+1.1%)
Dec 2023
-$606.64 M(-14.2%)
-$123.19 M(-22.8%)
-$606.64 M(-4.5%)
Sep 2023
-
-$159.65 M(-0.1%)
-$635.28 M(-11.9%)
Jun 2023
-
-$159.83 M(-2.5%)
-$720.74 M(+0.2%)
Mar 2023
-
-$163.97 M(+8.0%)
-$719.07 M(+1.6%)
Dec 2022
-$707.42 M(+55.8%)
-$151.83 M(-38.1%)
-$707.42 M(+4.3%)
Sep 2022
-
-$245.11 M(+55.0%)
-$678.05 M(+34.0%)
Jun 2022
-
-$158.16 M(+3.8%)
-$505.94 M(+7.6%)
Mar 2022
-
-$152.32 M(+24.4%)
-$470.20 M(+3.6%)
Dec 2021
-$454.02 M(+143.4%)
-$122.46 M(+67.8%)
-$454.02 M(+27.7%)
Sep 2021
-
-$73.00 M(-40.4%)
-$355.58 M(+1.2%)
Jun 2021
-
-$122.43 M(-10.1%)
-$351.43 M(+72.5%)
Mar 2021
-
-$136.14 M(+467.0%)
-$203.68 M(+9.2%)
Dec 2020
-$186.57 M(-53.7%)
-$24.01 M(-65.1%)
-$186.57 M(-27.2%)
Sep 2020
-
-$68.84 M(-372.0%)
-$256.36 M(-14.7%)
Jun 2020
-
$25.32 M(-121.3%)
-$300.51 M(-29.3%)
Mar 2020
-
-$119.03 M(+26.9%)
-$425.00 M(+5.5%)
Dec 2019
-$402.73 M(+103.8%)
-$93.81 M(-17.0%)
-$402.73 M(+1.5%)
Sep 2019
-
-$112.99 M(+13.9%)
-$396.75 M(+6.9%)
Jun 2019
-
-$99.17 M(+2.5%)
-$371.06 M(+14.3%)
Mar 2019
-
-$96.76 M(+10.2%)
-$324.62 M(+64.3%)
Dec 2018
-$197.61 M
-$87.83 M(+0.6%)
-$197.61 M(+3.2%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$87.31 M(+65.6%)
-$191.52 M(+4.4%)
Jun 2018
-
-$52.73 M(-274.3%)
-$183.43 M(-9.9%)
Mar 2018
-
$30.25 M(-137.0%)
-$203.60 M(-32.6%)
Dec 2017
-$302.14 M(+22.9%)
-$81.73 M(+3.2%)
-$302.14 M(+3.6%)
Sep 2017
-
-$79.23 M(+8.7%)
-$291.69 M(+5.2%)
Jun 2017
-
-$72.89 M(+6.7%)
-$277.38 M(+6.1%)
Mar 2017
-
-$68.29 M(-4.2%)
-$261.41 M(+6.3%)
Dec 2016
-$245.87 M(+68.8%)
-$71.29 M(+9.8%)
-$245.87 M(+7.0%)
Sep 2016
-
-$64.91 M(+14.0%)
-$229.81 M(+12.6%)
Jun 2016
-
-$56.92 M(+7.9%)
-$204.13 M(+15.3%)
Mar 2016
-
-$52.76 M(-4.5%)
-$177.00 M(+21.5%)
Dec 2015
-$145.62 M(+143.5%)
-$55.22 M(+40.8%)
-$145.62 M(+35.9%)
Sep 2015
-
-$39.23 M(+31.7%)
-$107.14 M(+27.9%)
Jun 2015
-
-$29.79 M(+39.3%)
-$83.75 M(+24.0%)
Mar 2015
-
-$21.38 M(+27.7%)
-$67.55 M(+13.0%)
Dec 2014
-$59.80 M(+70.5%)
-$16.74 M(+5.6%)
-$59.80 M(+10.0%)
Sep 2014
-
-$15.85 M(+16.7%)
-$54.38 M(+15.8%)
Jun 2014
-
-$13.59 M(-0.3%)
-$46.96 M(+11.9%)
Mar 2014
-
-$13.63 M(+20.4%)
-$41.97 M(+19.7%)
Dec 2013
-$35.07 M(+114.7%)
-$11.32 M(+34.3%)
-$35.07 M(+22.3%)
Sep 2013
-
-$8.43 M(-1.9%)
-$28.68 M(+41.6%)
Jun 2013
-
-$8.59 M(+27.5%)
-$20.25 M(+73.6%)
Mar 2013
-
-$6.74 M(+36.6%)
-$11.66 M(+136.6%)
Dec 2012
-$16.33 M(+138.5%)
-$4.93 M
-$4.93 M
Dec 2011
-$6.85 M
-
-

FAQ

  • What is Ultragenyx Pharmaceutical annual net profit?
  • What is the all time high annual net income for Ultragenyx Pharmaceutical?
  • What is Ultragenyx Pharmaceutical annual net income year-on-year change?
  • What is Ultragenyx Pharmaceutical quarterly net profit?
  • What is the all time high quarterly net income for Ultragenyx Pharmaceutical?
  • What is Ultragenyx Pharmaceutical quarterly net income year-on-year change?
  • What is Ultragenyx Pharmaceutical TTM net profit?
  • What is the all time high TTM net income for Ultragenyx Pharmaceutical?
  • What is Ultragenyx Pharmaceutical TTM net income year-on-year change?

What is Ultragenyx Pharmaceutical annual net profit?

The current annual net income of RARE is -$606.64 M

What is the all time high annual net income for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical all-time high annual net profit is -$6.85 M

What is Ultragenyx Pharmaceutical annual net income year-on-year change?

Over the past year, RARE annual net profit has changed by +$100.78 M (+14.25%)

What is Ultragenyx Pharmaceutical quarterly net profit?

The current quarterly net income of RARE is -$133.52 M

What is the all time high quarterly net income for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical all-time high quarterly net profit is $30.25 M

What is Ultragenyx Pharmaceutical quarterly net income year-on-year change?

Over the past year, RARE quarterly net profit has changed by +$26.13 M (+16.37%)

What is Ultragenyx Pharmaceutical TTM net profit?

The current TTM net income of RARE is -$558.99 M

What is the all time high TTM net income for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical all-time high TTM net profit is -$4.93 M

What is Ultragenyx Pharmaceutical TTM net income year-on-year change?

Over the past year, RARE TTM net profit has changed by +$76.29 M (+12.01%)